The extent of coronary stenosis and the level of antibodies to atherogenic lipoproteins in patients with coronary heart disease
- 作者: Urazgil'deeva S.A.1, Titkov A.Y.1, Vasina L.V.1, Tsaregorodtseva V.V.1, Gurevich V.S.1, Urazgildeeva SA2, Titkov AY.3, Vasina LV3, Tsaregorodtseva VV2, Gurevich VS2
-
隶属关系:
- I.I. Mechnikov State Medical Academy, Center for Atherosclerosis and Lipid Disorders, St-Petersburg
- L.G. Sokolov city hospital № 122, St-Petersburg
- 期: 卷 83, 编号 9 (2011)
- 页面: 10-13
- 栏目: Editorial
- ##submission.dateSubmitted##: 10.04.2020
- ##submission.datePublished##: 15.09.2011
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30887
- ID: 30887
如何引用文章
全文:
详细
Material and methods. Sixty CHD patients were examined for titer of anti-OLDL, levels of total cholesterol (TC), LDLP cholesterol, HDLP cholesterol, triglycerides. Selective coronarography (SC) was made on demand.
Results. Elevated titer of anti-OLDL was found only in 12 examinees. It was significantly lower in CHD women than in men. No significant differences by anti-OLDL were found in CHD patients with and without significant risk factors. SC registered in all CHD examinees local stenosis of different severity. Stenosis in 3 coronary arteries was detected in 31 cases, in 2 coronary arteries - in 14, in 1 coronary artery - in 15 patients, most frequently the affection was located in the diagonal branch of the left coronary artery. Stenosis of the left coronary artery trunk was diagnosed in one case. The correlation analysis revealed a strongly significant positive correlation between content of anti-OLDL and the degree of CS.
Conclusion. The level of anti-OLDL in CHD patients directly correlates with the degree of CS and is a marker of coronary atherosclerosis severity.
作者简介
Soreyya Urazgil'deeva
Email: s_urazgildeeva@hotmail.com
Aleksandr Titkov
Email: alextitkov76@mail.ru
Lyubov' Vasina
Email: lubov.vasina@gmail.com
Viktoriya Tsaregorodtseva
Email: vika.ru@rambler.ru
Viktor Gurevich
Email: ater@med122.com
S Urazgildeeva
I.I. Mechnikov State Medical Academy, Center for Atherosclerosis and Lipid Disorders, St-PetersburgI.I. Mechnikov State Medical Academy, Center for Atherosclerosis and Lipid Disorders, St-Petersburg
A Titkov
L.G. Sokolov city hospital № 122, St-PetersburgL.G. Sokolov city hospital № 122, St-Petersburg
L Vasina
L.G. Sokolov city hospital № 122, St-PetersburgL.G. Sokolov city hospital № 122, St-Petersburg
V Tsaregorodtseva
I.I. Mechnikov State Medical Academy, Center for Atherosclerosis and Lipid Disorders, St-PetersburgI.I. Mechnikov State Medical Academy, Center for Atherosclerosis and Lipid Disorders, St-Petersburg
V Gurevich
I.I. Mechnikov State Medical Academy, Center for Atherosclerosis and Lipid Disorders, St-PetersburgI.I. Mechnikov State Medical Academy, Center for Atherosclerosis and Lipid Disorders, St-Petersburg
参考
- Климов А. Н. Аутоиммунная теория атерогенеза и концепция модифицированных липопротеидов. Вестн. АМН СССР 1990; 11: 30-36.
- Sherer Y., Pauletto P., Shoenfeld Y. Atherosclerosis and Autoimmunity. Handbook of Systemic Autoimmune Disease.In: Doria A., Pauletto P. eds. The heart in systemic autoimmune diseases. Amsterdam. 2004. 89-95.
- Fitzgibbon G. M., Burggraf G. W., Groves T. D., Parker J. O. A double Master's two-step test: clinical, angiographic and hemodynamic correlation. Ann. Intern. Med. 1971; 74 (4): 509- 517.
- Friedwald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low density lipoprotein cholesterol in lasma without use of the preparative uitracentrifuge. Clin. Chem. 1972; 18 (6): 499-502.
- Насонов Е. Л., Алекберова З. С., Калашникова Л. А. и др. Антифосфолипидный синдром (синдром Hughes); 10 лет изучения в России. Клин. мед. 1998; 2: 4-11.
- Sherer Y., Shoenfeld Y. Antiphospholipid syndrome, antiphospholipid antibodies and atherosclerosis. Curr. Atheroscler.Rep. 2001; 3 (4): 328-333.
- Hamsten A., Norberg R., Bjorkholm M. et al. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet 1986; 1 (8473): 113-116.
- Насонов Е. Л., Карпов Ю. А., Алекберова З. С. и др. Антифосфолипидный синдром: кардиологические аспекты. Тер. арх. 1993; 11: 80-86.
- Holvoet P., Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 1994; 8 (15): 1279-1284.
- Vaarala O. Antibodies to oxidized LDL. Lupus 2000; 9 (3): 202-205.
- Гуревич В. С., Уразгильдеева С. А., Шатилина Л. В. и др. Изменение уровней антител к окисленным липопротеидам при применении аторвастатина у женщин с ишемической болезнью сердца в постменопаузе. Кардиология 2004; 4: 76-77.
- Maggy E., Perani G., Falaschi F. et al. Autoantibodies against oxidized low density lipoproteins in patients with coronary disease. Presse Med. 1994; 23 (25): 1158-1162.
- Erkkila F. T., Narvanen O., Lehto S. et al. Autoantibodies against oxidized low density lipoproteins and cardiolipin in patients with coronary heart disease. Arterioscler. Thromb. Vase. Biol. 2000; 20 (1): 204-209
- Lehtimaki T., Lehtinen S., Solakivi T. et al. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arterioscler. Thromb. Vase. Biol. 1999; 19 (1): 23-27.
- Puuronen M., Manttari M., Manninen V. et al. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch. Intern. Med. 1994; 154 (22): 2605-2609.
- Wu R., Nityanand S., Berglund L. et al. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. Arterioscler. Thromb. Vase. Biol. 1997; 17 (11): 3159-3163.
- George J., Harats D., Bakshi E. et al. Anti-oxidized ow density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty. Immunol.Lett. 1999; 68 (2-3): 263-266.
- Morton K. E., Gavaghan T. P., Krilis S. A. et al. Coronary artery bypass graft failure - an autoimmune phenomenon? Lancet 1986; 2 (8520): 1353-1357.
- Nilsson J., Regnstrom J., Frostegard J., Stiko A. Lipid oxidation and atherosclerosis. Herz 1992; 17 (5): 263-269.